Evidence map›Paper›PMID 36505748›Full record

ArticleFrontiers in chemistry2022

Mo@ZIF-8 nanozyme preparation and its antibacterial property evaluation.

Zheng Lian, Chunqing Lu, Jiangqi Zhu, Xining Zhang, Ting Wu, Youlin Xiong, Zhiyi Sun, Rong Yang

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Review
  3. Hydrothermally synthesized VSScientific reports · 2025
    Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. A fresh pH-responsive imipenem-loaded nanocarrier againstFrontiers in bioengineering and biotechnology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Zheng LianSchool of Criminal Investigation, People's Public Security University of China, Beijing, China.
Chunqing LuSchool of Criminal Investigation, People's Public Security University of China, Beijing, China.
Jiangqi ZhuSchool of Criminal Investigation, People's Public Security University of China, Beijing, China.
Xining ZhangCAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Center of Materials Science and Optoelectronics Engineering, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, University of Chinese Academy of Sciences, Beijing, China.
Ting WuCAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Center of Materials Science and Optoelectronics Engineering, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, University of Chinese Academy of Sciences, Beijing, China.
Youlin XiongCAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Center of Materials Science and Optoelectronics Engineering, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, University of Chinese Academy of Sciences, Beijing, China.
Zhiyi SunSchool of Criminal Investigation, People's Public Security University of China, Beijing, China.
Rong YangCAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Center of Materials Science and Optoelectronics Engineering, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, University of Chinese Academy of Sciences, Beijing, China.
National Center for Nanoscience and Technology · CNChina People's Public Security University · CNUniversity of Chinese Academy of Sciences · CNChina University of Political Science and Law · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Types of nanozymes can produce free radicals and/or reactive oxygen species (ROS) to serve as broad spectrum antibacterial materials. Developing nanozyme-based antibacterial materials with good biocompatibility exhibits promising application prospects. In this study, we doped Mo to ZIF-8 (both components have good biocompatibility) to prepare a new nanozyme, Mo@ZIF-8, which can produce hydroxyl radicals (•OH) triggered by a low dosage of hydrogen peroxide (H

Indexed as

antibacterial therapymetal organic frameworkmolybdenumperoxidase-like nanozymeZIF-8

Identifiers

PMID36505748
PMCPMC9730516
OpenAlexW4309857780

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.